Bavarian Nordic Reports Preliminary Financial Results for 2020

Revenue and EBITDA in line with guidance for 2020. Year-end cash position better than guided for 2020 COPENHAGEN, Denmark, January 28, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today reported preliminary, unaudited financial results for 2020 in line with or better than the Company’s most recent guidance. Revenue for the full year is… Continue reading Bavarian Nordic Reports Preliminary Financial Results for 2020

Bavarian Nordic to Supply Smallpox Vaccines to Three European Countries

COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European governments for the supply of IMVANEX® smallpox vaccine. The combined value of the contracts is EUR 11 million that will be revenue recognized during first half of 2021, where deliveries… Continue reading Bavarian Nordic to Supply Smallpox Vaccines to Three European Countries

Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government

COPENHAGEN, Denmark, December 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised an option covering the majority of the… Continue reading Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government

Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.

Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. 56 of the Danish Companies Act, has received notification from Invesco Ltd confirming that that Invesco Ltd., as of 9 November 2020,… Continue reading Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.

Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.

Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. 56 of the Danish Companies Act, has received notification from Invesco Ltd confirming that that Invesco Ltd., as of 9 November 2020,… Continue reading Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.

Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses

COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high… Continue reading Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses

Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses

COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox and related orthopoxvirus infections and disease in adults 18 years of age and older determined to be at high… Continue reading Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1. Details of the person discharging managerial responsibilities/person closely associated   a) Name Paul Chaplin 2. Reason for… Continue reading Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such